시장보고서
상품코드
2143381

유전자 융합 검사 시장 : 카테고리별, 기술별, 적응증별, 최종사용자별, 국가별, 지역별 - 업계 분석, 시장 규모, 시장 점유율 및 예측(2026-2033년)

Gene Fusion Testing Market, By Category, By Technology, By Indication, By End User, By Country, and By Region -Global Industry Analysis, Market Size, Market Share & Forecast from 2026-2033

발행일: | 리서치사: 구분자 AnalystView Market Insights | 페이지 정보: 영문 350 Pages | 배송안내 : 2-3일 (영업일 기준)

    
    
    




가격
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 불가능하며, 텍스트의 Copy&Paste도 불가능합니다.
US $ 3,250 금액 안내 화살표 ₩ 4,354,000
PDF (5 User License) help
PDF 보고서를 동일 사업장에서 5명까지 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 4,560 금액 안내 화살표 ₩ 6,109,000
PDF & Excel (Enterprise User License) help
PDF & Excel 보고서를 동일 기업 내 모든 사용자가 사용할 수 있는 라이선스입니다. 텍스트의 Copy&Paste 가능합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 5,650 금액 안내 화살표 ₩ 7,569,000
※ 부가세 별도
한글목차
영문목차
※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

유전자 융합 검사 시장 규모는 2025년에 8억 3,010만 달러로 평가되었고, 2026-2033년 CAGR 13.1%를 기록할 전망입니다.

전 세계 유전자 융합 검사 시장은 종양학을 포함한 다양한 질환의 발병 과정에서 발생하는 유전자 융합 등의 유전자 변이를 검사하기 위해 특별히 개발된 분자진단 및 정밀 의학의 한 분야를 의미합니다. 유전자 전좌 검사는 암 발병으로 이어지는 단백질 변이를 특정하기 위해 사용됩니다. 신기술에 대한 수요가 끊임없이 증가하는 가운데, 전 세계 유전자 융합 검사 시장은 정밀의료 분야에서 필수적인 요소로 자리매김하며, 환자의 유전적 배경에 기반한 맞춤형 치료 접근법의 실현을 가능하게 하고 있습니다.

전 세계 유전자 융합 검사 시장은 유전적 이상에 관한 정보를 바탕으로 암 치료를 개인화하는 데 있어 중요한 분야로 자리 잡고 있습니다. 전 세계 유전자 융합 검사 시장에서는 다양한 유형의 암에서 유전자 전좌를 검출하기 위해 NGS(차세대 염기서열 분석), FISH(형광 in situ 하이브리다이제이션),PCR(중합효소 연쇄반응) 등 여러 기술이 활용되고 있습니다. 이러한 기술들은 유전자 융합의 검출 정확도를 높여, 정확한 진단과 표적화된 암 치료 방침의 결정을 지원합니다.

유전자 융합 검사 시장 -- 시장 역학

암 유병률 증가가 시장 확대를 가속화

암 유병률 증가는 유전자 융합 검사 수요를 견인하고 있습니다. 이는 암 환자 수 증가에 따라 치료에 활용할 수 있는 돌연변이를 특정하거나 개별 증례에 맞춘 치료 계획을 수립하기 위한 정확한 분자 검사의 필요성이 높아지고 있기 때문입니다. 예를 들어, 2026년 3월 유로스타트(Eurostat) 데이터에 따르면, EU에서 암은 사망 원인 2위를 차지했으며, 같은 기간 전체 사망자 수 중 약 116만 명(23.9%)이 암으로 인한 것이었습니다. 암 사례는 고령층에서 더 많이 나타나며, 65세 이상 주민 10만 명당 표준화 사망률은 936건인 반면, 65세 미만 젊은 층의 사망률은 10만 명당 62.9건이었습니다. EU 전체의 암에 의한 표준화 사망률은 주민 10만 명당 233.1건이었으나, 남성의 경우 10만 명당 302.8건, 여성은 183.7건이었습니다. 이러한 추세에 따라 암 진단 및 치료 계획 수립 과정에서 유전자 융합 검사에 대한 수요가 가속화될 것으로 예측됩니다.

유전자 융합 검사 시장 - 시장 세분화 분석 :

전 세계 유전자 융합 검사 시장은 카테고리, 기술, 적응증, 최종 사용자 및 지역을 기준으로 세분화되어 있습니다.

기술별로는 중합효소 연쇄반응(PCR)이 높은 민감도와 신속한 결과 보고는 물론, 암 환자 선별 검사 및 분자 프로파일링에서 유전자 융합 검출에 폭넓게 활용됨에 따라 유전자 융합 검사 시장에서 중요한 위치를 차지하고 있습니다. 예를 들어, 2025년 2월 PLOS ONE(Org.)의 보고에 따르면, 고빈도 PCR 검사법이 약 3,421명의 의료 종사자 및 약 28만 5,000건의 구강 면봉 검체에 적용되었습니다. 백신을 접종하지 않은 의료 종사자에게는 주 2회 PCR 검사가 의무화되었고, 모든 의료 종사자에게도 주 2회 PCR 검사가 의무화된 결과,SARS-CoV-2에 대한 지속적인 감시를 실시하고 있는 독일의 요양 시설에서는 월간 총 1만 7,940건의 PCR 검사가 수행되었으며, 그중 1만 7,479건이 실시되었습니다. 이러한 기술을 통해 임상적으로 유용한 유전자 융합 현상을 신뢰성 높고, 효율적이며 신속하게 검출할 수 있게 되었습니다.

유전자 융합 검사 시장 - 지역별 분석

지역별로 보면, 아시아태평양은 진단 기업의 진출과 분자진단에 대한 투자가 증가하고 있어, 전 세계 유전자 융합 검사 시장에서 성장이 기대되는 지역으로 예측됩니다. 예를 들어, 2026년 6월, 인도 브랜드 에퀴티 재단(IBEF)은 인도의 진단 기기 시장이 2023년(40억 달러)에 비해 2027년에는(60억 달러)에 달할 것이라고 발표했습니다. 수요가 현저히 증가하고 있어, 이는 진단 기기 제조업체들에게 인도 지역에서의 입지를 강화할 수 있는 좋은 기회가 되고 있습니다. 또한, 헬스케어, 병원 인프라, 보험 적용 범위에 대한 수요가 증가함에 따라 인도의 의료기기 시장은 2025년(152억 달러)에서 2030년에는(501억 달러)에 달할 것으로 예측됩니다. 이러한 추세에 따라 아시아태평양 전체의 진단 역량이 강화되고, 유전자 융합 검사 도입이 가속화될 것으로 전망됩니다.

싱가포르 유전자 융합 검사 시장 - 국가별 인사이트

싱가포르에서는 동반 진단 및 분자진단에 대한 승인 및 규제 절차가 신속하게 마련되어 있어, 이를 통해 시장 출시 기간이 단축되고 혁신의 확산이 촉진되고 있습니다. 2025년 8월 현재, 싱가포르 경제개발청(정부 기관)에 따르면, 싱가포르의 현지 기업 및 세계 기업으로 구성된 생태계는 총 400개사 이상에 달하며, 1만 7,000명 이상을 고용하고 있습니다. 또한, 세계 최고 수준의 의료 기술(MedTech) 기업에는 싱가포르에서 사업을 전개하고 있는 상위 30개 다국적 기업(MNC)이 포함되어 있습니다. 이 의료 기술 기업들은 콘택트렌즈와 심장 임플란트 등을 포함해 연간 총액 190억 싱가포르 달러를 넘는 고부가가치 의료기기를 제조하고 있으며, 가장 놀라운 사실 중 하나는 실로 놀라운 일이지만, 상위 30개 다국적 기업 중 20개 이상 기업이 싱가포르에 연구개발 센터를 설립하고 있다는 점입니다.

또한, 싱가포르의 ‘국가 정밀의료 이니셔티브’ 및 ‘SG100K 프로그램’에서는 2031년까지 싱가포르 총인구의 약 10%를 대상으로 생활 습관, 임상적 요인,유전체 정보, 환경적 요인 등 대규모 데이터 포인트에 대한 상세한 분석을 수행할 예정이며, 대상인 10만 명의 싱가포르인 전원이 유전체 염기서열 분석 및 해석을 받게 됩니다. 이러한 모든 역량은 의료 영상을 보다 신속하고 정확하게 처리하는 AI 기반 진단, 암 위험 모델링, 선천성 난청 위험 예측 등을 포함한 첨단 진단 기술의 개발을 촉진하는 데 기여할 것입니다.

목차

제1장 유전자 융합 검사 시장 개요

제2장 주요 요약

제3장 유전자 융합 검사 주요 시장 동향

제4장 유전자 융합 검사 산업 분석

제5장 유전자 융합 검사 시장 : 높아지는 지정학적 긴장의 영향

제6장 유전자 융합 검사 시장 구도

제7장 유전자 융합 검사 시장 : 카테고리별

제8장 유전자 융합 검사 시장 : 기술별

제9장 유전자 융합 검사 시장 : 적응증별

제10장 유전자 융합 검사 시장 : 최종사용자별

제11장 유전자 융합 검사 시장 : 지역별

제12장 주요 벤더 분석 : 유전자 융합 검사 산업

제13장 AnalystView 전방위 전망

LSH 26.10.19

Gene Fusion Testing market size was valued at US$ 830.1 Million in 2025, expanding at a CAGR of 13.1% from 2026 to 2033.

The global Gene Fusion Testing market refers to that part of molecular diagnostics and precision medicine that was developed specifically for testing genetic mutations, including gene fusions, occurring during the process of various diseases' development, including oncology. A gene translocation test is used for identifying protein mutations that result in the development of cancer. As the demand for new technologies has been constantly rising, the global Gene Fusion Testing market has become an integral part of the field of precision medicine, allowing for creating a personalized approach to treating patients based on their genetic background.

The global Gene Fusion Testing market represents a key field for personalizing cancer therapy on the basis of information about genetic abnormalities. There are several technologies that are used in the global Gene Fusion Testing market for the purpose of detecting gene translocations in cases of different kinds of cancer, such as NGS (next generation sequencing), FISH (fluorescence in situ hybridization), and PCR (polymerase chain reaction). These technologies enhance gene fusion detection, supporting accurate diagnosis and targeted cancer treatment decision.

Gene Fusion Testing Market- Market Dynamics

Increasing Cancer Disease Prevalence to Accelerate Market Expansion

The increasing prevalence of cancer is driving demand for gene fusion testing because of the growing number of cancer patients, who increase the need for accurate molecular tests for actionable mutations and for treatment planning in each particular case. For example, in March 2026, according to Eurostat, cancer was the second most common cause of deaths in the EU, and there were about 1.16 million cases (23.9%) out of all deaths in this period. The cancer cases were more common among the elder population, as the standardized death rate was 936.0 cases per 100,000 inhabitants over 65 years of age, while the death rate among the younger population was 62.9 per 100,000 inhabitants under 65 years of age. There were 233.1 cases of cancer per 100,000 inhabitants in the total EU standardized death rate from cancer, while the death rate among males was 302.8 cases and among females was 183.7 cases per 100,000 inhabitants. These trends are expected to accelerate demand for gene fusion testing in cancer diagnosis and treatment planning.

Gene Fusion Testing Market- Segmentation Analysis:

The Global Gene Fusion Testing market is segmented on the basis of Category, Technology, Indication, End User, and Region.

Based on technology, Polymerase Chain Reaction (PCR) holds an important position in the Gene Fusion Testing market due to greater sensitivity and quick turnaround time as well as greater applications in the detection of gene fusions for screening and molecular profiling of cancer patients. For instance, in February 2025, according to a PLOS ONE (Org.), the high-frequency PCR testing method was used for about 3,421 healthcare workers and in around 285,000 oral swab samples. Unvaccinated healthcare workers were mandated to do PCR tests twice a week; all healthcare workers were mandated to do PCR tests twice a week, leading to a total of 17,940 PCR tests and 17,479 in a month at a German care facility conducting continuous surveillance of SARS-CoV-2. These technologies facilitate reliable, efficient, and quick detection of clinically actionable gene fusion events.

Gene Fusion Testing Market- Geographical Insights

Based on region, Asia-Pacific is projected to be the growing region in the global Gene Fusion Testing market due to the rising presence of diagnostic companies and investments in molecular diagnostics. For example, in June 2026, the India Brand Equity Foundation (IBEF) stated that India's market for diagnostic devices will achieve ($6,000 million) in 2027, as compared to or ($4,000 million) in CY23. There is significant growth in the demand, which offers an opportunity to diagnostic companies to increase their presence in the Indian region. Moreover, India's market for medical devices is forecasted to reach from ($15,200 million) in 2025 to ($50,100 million) in 2030 because of the growing demand for healthcare, hospital infrastructure, and insurance coverage. This trend is expected to strengthen diagnostic capabilities and accelerate gene fusion testing adoption across Asia-Pacific.

Singapore Gene Fusion Testing Market - Country Insights

Singapore is developing rapid routes towards approving and regulating companion and molecular diagnostics, and this ensures faster time-to-market and increased adoption of innovations. In August 2025, according to the Singapore Economic Development Board (Gov), Singapore's ecosystem of companies, either local or global, amounts to a total of more than 400 companies employing over 17,000 individuals, and the topmost MedTech companies of the world include the top 30 MNCs, which are operating in Singapore. These MedTech companies manufacture a total value of more than S$19 billion SGD of high-value medical devices per year, which includes, among others, contact lenses and cardiac implants, and one of the most amazing facts, which is indeed amazing, is that out of the total 30 MNCs, more than 20 companies set up R&D centres in Singapore.

And the nation's National Precision Medicine Initiative and SG100K Programme expect Singapore to conduct a detailed analysis of large data points like lifestyles, clinical factors, genomics, and environmental factors of around ten per cent of the total population of Singapore up to 2031, and all of the 100,000 Singaporeans will undergo genomic sequencing and analysis. All of these capabilities go on to facilitate the development of advanced diagnostic technologies, which include AI-based diagnostics that process medical images faster and more accurately, cancer-risk modelling, congenital hearing loss risk prediction, and others.

Gene Fusion Testing Market- Competitive Landscape:

Technological innovations, investments, and finance are key drivers that propel the worldwide Gene Fusion Testing market forward. There are some well-known companies like Roche, Guardant Health, Illumina, Biocartis, and Amoy Diagnostics that are contributing to technology development in order to drive the growth of the global market of gene fusion testing, along with the use of the above-mentioned technology to conduct gene fusion testing. In May 2026, Roche signed an agreement with PathAI, buying the company for $750 million in cash upfront and $300 million in milestones, and this will help Roche be a better competitor in the industry of digital pathology and companion diagnostics using artificial intelligence. These strategic developments are expected to accelerate innovation and expand gene fusion testing capabilities.

Recent Developments:

In July 2025, Amoy Diagnostics, Riken Genesis, and Precision Medicine Asia have announced that the AmoyDx(R) Pan Lung Cancer PCR Panel is an approved companion diagnostic for amivantamab and lazertinib in Japan. It is a complete test kit for screening of mutations in various genes like EGFR, ALK, ROS1, KRAS, BRAF, HER2, RET, MET, NTRK1, NTRK2, and NTRK3, including ALK, ROS1, and RET gene fusions.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL GENE FUSION TESTING MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Amoy Diagnostics Co., Ltd.
  • Arima Genomics, Inc.
  • Biocare Medical, LLC
  • Biocartis NV
  • Caris Life Sciences
  • Danaher Corporation
  • Empire Genomics, Inc.
  • F. Hoffmann-La Roche Ltd.
  • Guardant Health, Inc.
  • Illumina, Inc.
  • Integrated DNA Technologies, Inc. (ArcherDX)
  • Myriad Genetics, Inc.
  • Natera, Inc.
  • NeoGenomics, Inc.
  • OncoDNA SA
  • Paragon Genomics, Inc.
  • QIAGEN N.V.
  • Thermo Fisher Scientific Inc.
  • Others

GLOBAL GENE FUSION TESTING MARKET, BY CATEGORY- MARKET ANALYSIS, 2020 - 2033

  • Diagnostic
  • Research

GLOBAL GENE FUSION TESTING MARKET, BY TECHNOLOGY- MARKET ANALYSIS, 2020 - 2033

  • Immunohistochemistry (IHC)
  • Polymerase Chain Reaction (PCR)
  • Fluorescence In-Situ Hybridization (FISH)
  • Next-Generation Sequencing (NGS)

GLOBAL GENE FUSION TESTING MARKET, BY INDICATION- MARKET ANALYSIS, 2020 - 2033

  • Hematological Malignancies
  • Solid Tumors

GLOBAL GENE FUSION TESTING MARKET, BY END USER- MARKET ANALYSIS, 2020 - 2033

  • Academic & Research Centers
  • Hospitals and Diagnostic Laboratories
  • Pharmaceutical and Biotechnology Companies
  • Others

GLOBAL GENE FUSION TESTING MARKET, BY REGION- MARKET ANALYSIS, 2020 - 2033

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Denmark
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Taiwan
  • Vietnam
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Iran
  • Qatar
  • Rest of MEA

Table of Contents

1. Gene Fusion Testing Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Gene Fusion Testing Market Snippet by Category
    • 2.1.2. Gene Fusion Testing Market Snippet by Technology
    • 2.1.3. Gene Fusion Testing Market Snippet by Indication
    • 2.1.4. Gene Fusion Testing Market Snippet by End User
    • 2.1.5. Gene Fusion Testing Market Snippet by Country
    • 2.1.6. Gene Fusion Testing Market Snippet by Region
  • 2.2. Competitive Insights

3. Gene Fusion Testing Key Market Trends

  • 3.1. Gene Fusion Testing Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Gene Fusion Testing Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Gene Fusion Testing Market Opportunities
  • 3.4. Gene Fusion Testing Market Future Trends

4. Gene Fusion Testing Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Gene Fusion Testing Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Gene Fusion Testing Market Landscape

  • 6.1. Gene Fusion Testing Market Share Analysis, 2025
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Gene Fusion Testing Market - By Category

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Category, 2025 & 2033 (%)
    • 7.1.2. Diagnostic
    • 7.1.3. Research

8. Gene Fusion Testing Market - By Technology

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Technology, 2025 & 2033 (%)
    • 8.1.2. Immunohistochemistry (IHC)
    • 8.1.3. Polymerase Chain Reaction (PCR)
    • 8.1.4. Fluorescence In-Situ Hybridization (FISH)
    • 8.1.5. Next-Generation Sequencing (NGS)

9. Gene Fusion Testing Market - By Indication

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Indication, 2025 & 2033 (%)
    • 9.1.2. Hematological Malignancies
    • 9.1.3. Solid Tumors

10. Gene Fusion Testing Market - By End User

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By End User, 2025 & 2033 (%)
    • 10.1.2. Academic & Research Centers
    • 10.1.3. Hospitals and Diagnostic Laboratories
    • 10.1.4. Pharmaceutical and Biotechnology Companies
    • 10.1.5. Others

11. Gene Fusion Testing Market - By Geography

  • 11.1. Introduction
    • 11.1.1. Segment Share Analysis, By Geography, 2025 & 2033 (%)
  • 11.2. North America
    • 11.2.1. Overview
    • 11.2.2. Gene Fusion Testing Key Manufacturers in North America
    • 11.2.3. North America Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 11.2.4. North America Market Size and Forecast, By Category, 2020 - 2033 (US$ Million)
    • 11.2.5. North America Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.2.6. North America Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
    • 11.2.7. North America Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.2.8. U.S.
      • 11.2.8.1. Overview
      • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.2.8.3. U.S. Market Size and Forecast, By Category, 2020 - 2033 (US$ Million)
      • 11.2.8.4. U.S. Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 11.2.8.5. U.S. Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
      • 11.2.8.6. U.S. Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.2.9. Canada
      • 11.2.9.1. Overview
      • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.2.9.3. Canada Market Size and Forecast, By Category, 2020 - 2033 (US$ Million)
      • 11.2.9.4. Canada Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 11.2.9.5. Canada Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
      • 11.2.9.6. Canada Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 11.3. Europe
    • 11.3.1. Overview
    • 11.3.2. Gene Fusion Testing Key Manufacturers in Europe
    • 11.3.3. Europe Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 11.3.4. Europe Market Size and Forecast, By Category, 2020 - 2033 (US$ Million)
    • 11.3.5. Europe Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.3.6. Europe Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
    • 11.3.7. Europe Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.3.8. Germany
      • 11.3.8.1. Overview
      • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.3.8.3. Germany Market Size and Forecast, By Category, 2020 - 2033 (US$ Million)
      • 11.3.8.4. Germany Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 11.3.8.5. Germany Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
      • 11.3.8.6. Germany Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.3.9. UK
      • 11.3.9.1. Overview
      • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.3.9.3. UK Market Size and Forecast, By Category, 2020 - 2033 (US$ Million)
      • 11.3.9.4. UK Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 11.3.9.5. UK Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
      • 11.3.9.6. UK Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.3.10. France
      • 11.3.10.1. Overview
      • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.3.10.3. France Market Size and Forecast, By Category, 2020 - 2033 (US$ Million)
      • 11.3.10.4. France Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 11.3.10.5. France Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
      • 11.3.10.6. France Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.3.11. Italy
      • 11.3.11.1. Overview
      • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.3.11.3. Italy Market Size and Forecast, By Category, 2020 - 2033 (US$ Million)
      • 11.3.11.4. Italy Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 11.3.11.5. Italy Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
      • 11.3.11.6. Italy Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.3.12. Spain
      • 11.3.12.1. Overview
      • 11.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.3.12.3. Spain Market Size and Forecast, By Category, 2020 - 2033 (US$ Million)
      • 11.3.12.4. Spain Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 11.3.12.5. Spain Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
      • 11.3.12.6. Spain Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.3.13. The Netherlands
      • 11.3.13.1. Overview
      • 11.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.3.13.3. The Netherlands Market Size and Forecast, By Category, 2020 - 2033 (US$ Million)
      • 11.3.13.4. The Netherlands Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 11.3.13.5. The Netherlands Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
      • 11.3.13.6. The Netherlands Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.3.14. Sweden
      • 11.3.14.1. Overview
      • 11.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.3.14.3. Sweden Market Size and Forecast, By Category, 2020 - 2033 (US$ Million)
      • 11.3.14.4. Sweden Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 11.3.14.5. Sweden Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
      • 11.3.14.6. Sweden Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.3.15. Russia
      • 11.3.15.1. Overview
      • 11.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.3.15.3. Russia Market Size and Forecast, By Category, 2020 - 2033 (US$ Million)
      • 11.3.15.4. Russia Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 11.3.15.5. Russia Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
      • 11.3.15.6. Russia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.3.16. Poland
      • 11.3.16.1. Overview
      • 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.3.16.3. Poland Market Size and Forecast, By Category, 2020 - 2033 (US$ Million)
      • 11.3.16.4. Poland Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 11.3.16.5. Poland Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
      • 11.3.16.6. Poland Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.3.17. Denmark
      • 11.3.17.1. Overview
      • 11.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.3.17.3. Denmark Market Size and Forecast, By Category, 2020 - 2033 (US$ Million)
      • 11.3.17.4. Denmark Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 11.3.17.5. Denmark Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
      • 11.3.17.6. Denmark Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.3.18. Rest of Europe
      • 11.3.18.1. Overview
      • 11.3.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.3.18.3. Rest of the Europe Market Size and Forecast, By Category, 2020 - 2033 (US$ Million)
      • 11.3.18.4. Rest of the Europe Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 11.3.18.5. Rest of the Europe Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
      • 11.3.18.6. Rest of the Europe Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 11.4. Asia Pacific (APAC)
    • 11.4.1. Overview
    • 11.4.2. Gene Fusion Testing Key Manufacturers in Asia Pacific
    • 11.4.3. APAC Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 11.4.4. APAC Market Size and Forecast, By Category, 2020 - 2033 (US$ Million)
    • 11.4.5. APAC Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.4.6. APAC Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
    • 11.4.7. APAC Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.4.8. China
      • 11.4.8.1. Overview
      • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.4.8.3. China Market Size and Forecast, By Category, 2020 - 2033 (US$ Million)
      • 11.4.8.4. China Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 11.4.8.5. China Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
      • 11.4.8.6. China Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.4.9. India
      • 11.4.9.1. Overview
      • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.4.9.3. India Market Size and Forecast, By Category, 2020 - 2033 (US$ Million)
      • 11.4.9.4. India Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 11.4.9.5. India Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
      • 11.4.9.6. India Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.4.10. Japan
      • 11.4.10.1. Overview
      • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.4.10.3. Japan Market Size and Forecast, By Category, 2020 - 2033 (US$ Million)
      • 11.4.10.4. Japan Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 11.4.10.5. Japan Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
      • 11.4.10.6. Japan Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.4.11. South Korea
      • 11.4.11.1. Overview
      • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.4.11.3. South Korea Market Size and Forecast, By Category, 2020 - 2033 (US$ Million)
      • 11.4.11.4. South Korea Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 11.4.11.5. South Korea Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
      • 11.4.11.6. South Korea Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.4.12. Australia
      • 11.4.12.1. Overview
      • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.4.12.3. Australia Market Size and Forecast, By Category, 2020 - 2033 (US$ Million)
      • 11.4.12.4. Australia Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 11.4.12.5. Australia Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
      • 11.4.12.6. Australia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.4.13. Indonesia
      • 11.4.13.1. Overview
      • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.4.13.3. Indonesia Market Size and Forecast, By Category, 2020 - 2033 (US$ Million)
      • 11.4.13.4. Indonesia Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 11.4.13.5. Indonesia Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
      • 11.4.13.6. Indonesia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.4.14. Thailand
      • 11.4.14.1. Overview
      • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.4.14.3. Thailand Market Size and Forecast, By Category, 2020 - 2033 (US$ Million)
      • 11.4.14.4. Thailand Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 11.4.14.5. Thailand Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
      • 11.4.14.6. Thailand Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.4.15. Philippines
      • 11.4.15.1. Overview
      • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.4.15.3. Philippines Market Size and Forecast, By Category, 2020 - 2033 (US$ Million)
      • 11.4.15.4. Philippines Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 11.4.15.5. Philippines Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
      • 11.4.15.6. Philippines Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.4.16. Taiwan
      • 11.4.16.1. Overview
      • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.4.16.3. Taiwan Market Size and Forecast, By Category, 2020 - 2033 (US$ Million)
      • 11.4.16.4. Taiwan Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 11.4.16.5. Taiwan Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
      • 11.4.16.6. Taiwan Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.4.17. Vietnam
      • 11.4.17.1. Overview
      • 11.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.4.17.3. Vietnam Market Size and Forecast, By Category, 2020 - 2033 (US$ Million)
      • 11.4.17.4. Vietnam Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 11.4.17.5. Vietnam Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
      • 11.4.17.6. Vietnam Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.4.18. Rest of APAC
      • 11.4.18.1. Overview
      • 11.4.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.4.18.3. Rest of APAC Market Size and Forecast, By Category, 2020 - 2033 (US$ Million)
      • 11.4.18.4. Rest of APAC Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 11.4.18.5. Rest of APAC Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
      • 11.4.18.6. Rest of APAC Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 11.5. Latin America (LATAM)
    • 11.5.1. Overview
    • 11.5.2. Gene Fusion Testing Key Manufacturers in Latin America
    • 11.5.3. LATAM Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 11.5.4. LATAM Market Size and Forecast, By Category, 2020 - 2033 (US$ Million)
    • 11.5.5. LATAM Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.5.6. LATAM Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
    • 11.5.7. LATAM Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.5.8. Brazil
      • 11.5.8.1. Overview
      • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.5.8.3. Brazil Market Size and Forecast, By Category, 2020 - 2033 (US$ Million)
      • 11.5.8.4. Brazil Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 11.5.8.5. Brazil Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
      • 11.5.8.6. Brazil Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.5.9. Mexico
      • 11.5.9.1. Overview
      • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.5.9.3. Mexico Market Size and Forecast, By Category, 2020 - 2033 (US$ Million)
      • 11.5.9.4. Mexico Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 11.5.9.5. Mexico Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
      • 11.5.9.6. Mexico Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.5.10. Argentina
      • 11.5.10.1. Overview
      • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.5.10.3. Argentina Market Size and Forecast, By Category, 2020 - 2033 (US$ Million)
      • 11.5.10.4. Argentina Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 11.5.10.5. Argentina Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
      • 11.5.10.6. Argentina Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.5.11. Colombia
      • 11.5.11.1. Overview
      • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.5.11.3. Colombia Market Size and Forecast, By Category, 2020 - 2033 (US$ Million)
      • 11.5.11.4. Colombia Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 11.5.11.5. Colombia Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
      • 11.5.11.6. Colombia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.5.12. Rest of LATAM
      • 11.5.12.1. Overview
      • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Category, 2020 - 2033 (US$ Million)
      • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 11.5.12.5. Rest of LATAM Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
      • 11.5.12.6. Rest of LATAM Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 11.6. Middle East and Africa (MEA)
    • 11.6.1. Overview
    • 11.6.2. Gene Fusion Testing Key Manufacturers in Middle East and Africa
    • 11.6.3. MEA Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 11.6.4. MEA Market Size and Forecast, By Category, 2020 - 2033 (US$ Million)
    • 11.6.5. MEA Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.6.6. MEA Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
    • 11.6.7. MEA Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.6.8. Saudi Arabia
      • 11.6.8.1. Overview
      • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Category, 2020 - 2033 (US$ Million)
      • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 11.6.8.5. Saudi Arabia Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
      • 11.6.8.6. Saudi Arabia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.6.9. United Arab Emirates
      • 11.6.9.1. Overview
      • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Category, 2020 - 2033 (US$ Million)
      • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 11.6.9.5. United Arab Emirates Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
      • 11.6.9.6. United Arab Emirates Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.6.10. Israel
      • 11.6.10.1. Overview
      • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.6.10.3. Israel Market Size and Forecast, By Category, 2020 - 2033 (US$ Million)
      • 11.6.10.4. Israel Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 11.6.10.5. Israel Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
      • 11.6.10.6. Israel Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.6.11. Turkey
      • 11.6.11.1. Overview
      • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.6.11.3. Turkey Market Size and Forecast, By Category, 2020 - 2033 (US$ Million)
      • 11.6.11.4. Turkey Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 11.6.11.5. Turkey Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
      • 11.6.11.6. Turkey Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.6.12. Algeria
      • 11.6.12.1. Overview
      • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.6.12.3. Algeria Market Size and Forecast, By Category, 2020 - 2033 (US$ Million)
      • 11.6.12.4. Algeria Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 11.6.12.5. Algeria Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
      • 11.6.12.6. Algeria Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.6.13. Egypt
      • 11.6.13.1. Overview
      • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.6.13.3. Egypt Market Size and Forecast, By Category, 2020 - 2033 (US$ Million)
      • 11.6.13.4. Egypt Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 11.6.13.5. Egypt Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
      • 11.6.13.6. Egypt Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.6.14. Iran
      • 11.6.14.1. Overview
      • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.6.14.3. Iran Market Size and Forecast, By Category, 2020 - 2033 (US$ Million)
      • 11.6.14.4. Iran Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 11.6.14.5. Iran Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
      • 11.6.14.6. Iran Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.6.15. Qatar
      • 11.6.15.1. Overview
      • 11.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.6.15.3. Qatar Market Size and Forecast, By Category, 2020 - 2033 (US$ Million)
      • 11.6.15.4. Qatar Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 11.6.15.5. Qatar Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
      • 11.6.15.6. Qatar Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.6.16. Rest of MEA
      • 11.6.16.1. Overview
      • 11.6.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.6.16.3. Rest of MEA Market Size and Forecast, By Category, 2020 - 2033 (US$ Million)
      • 11.6.16.4. Rest of MEA Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 11.6.16.5. Rest of MEA Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
      • 11.6.16.6. Rest of MEA Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)

12. Key Vendor Analysis- Gene Fusion Testing Industry

  • 12.1. Competitive Benchmarking
    • 12.1.1. Competitive Dashboard
    • 12.1.2. Competitive Positioning
  • 12.2. Company Profiles
    • 12.2.1. Amoy Diagnostics Co., Ltd.
    • 12.2.2. Arima Genomics, Inc.
    • 12.2.3. Biocare Medical, LLC
    • 12.2.4. Biocartis NV
    • 12.2.5. Caris Life Sciences
    • 12.2.6. Danaher Corporation
    • 12.2.7. Empire Genomics, Inc.
    • 12.2.8. F. Hoffmann-La Roche Ltd.
    • 12.2.9. Guardant Health, Inc.
    • 12.2.10. Illumina, Inc.
    • 12.2.11. Integrated DNA Technologies, Inc. (ArcherDX)
    • 12.2.12. Myriad Genetics, Inc.
    • 12.2.13. Natera, Inc.
    • 12.2.14. NeoGenomics, Inc.
    • 12.2.15. OncoDNA SA
    • 12.2.16. Paragon Genomics, Inc.
    • 12.2.17. QIAGEN N.V.
    • 12.2.18. Thermo Fisher Scientific Inc.
    • 12.2.19. Others

13. 360 Degree AnalystView

14. Appendix

  • 14.1. Research Methodology
  • 14.2. References
  • 14.3. Abbreviations
  • 14.4. Disclaimer
  • 14.5. Contact Us
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제
문의
원하시는 정보를
찾아 드릴까요?
문의주시면 필요한 정보를
신속하게 찾아드릴게요.
02-2025-2992
email
문의하기